Bruce C Cozadd Jazz Pharmaceuticals PLC (JAZZ) insider trading activity

Bruce C Cozadd is Chairman & CEO of Jazz Pharmaceuticals plc. Currently has a direct ownership of 437,973 shares of JAZZ, which is worth approximately $46.8 Million. The most recent transaction as insider was on Jun 03, 2025, when has been sold 500 shares (Ordinary Shares) at a price of $110.0 per share, resulting in proceeds of $55,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 438K

0.87% 3M change

1.9% 12M change

Total Value Held $46.8 Million

BRUCE C COZADD Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 03 2025	SELL Open market or private sale	$55,000 $110.0 p/Share	500 Reduced 0.11%	437,973 Ordinary Shares
Jun 02 2025	SELL Open market or private sale	$53,950 $107.9 p/Share	500 Reduced 0.11%	438,473 Ordinary Shares
May 02 2025	SELL Open market or private sale	$60,000 $120.0 p/Share	500 Reduced 0.11%	438,807 Ordinary Shares
May 01 2025	SELL Open market or private sale	$116,350 $116.35 p/Share	1,000 Reduced 0.23%	439,307 Ordinary Shares
Apr 01 2025	SELL Open market or private sale	$185,625 $123.75 p/Share	1,500 Reduced 0.34%	440,307 Ordinary Shares
Mar 05 2025	SELL Sale (or disposition) back to the issuer	$3,091,776 $138.95 p/Share	22,251 Reduced 4.79%	441,807 Ordinary Shares
Mar 03 2025	SELL Open market or private sale	$937,625 $144.25 p/Share	6,500 Reduced 1.38%	464,058 Ordinary Shares
Feb 27 2025	BUY Grant, award, or other acquisition	-	30,814 Added 6.15%	470,558 Ordinary Shares
Feb 03 2025	SELL Open market or private sale	$183,465 $122.31 p/Share	1,500 Reduced 0.34%	439,744 Ordinary Shares
Jan 17 2025	SELL Payment of exercise price or tax liability	$1,697,060 $122.62 p/Share	13,840 Reduced 3.04%	441,244 Ordinary Shares
Jan 17 2025	BUY Grant, award, or other acquisition	-	29,559 Added 6.1%	455,084 Ordinary Shares
Jan 02 2025	SELL Open market or private sale	$185,145 $123.43 p/Share	1,500 Reduced 0.35%	425,525 Ordinary Shares
Dec 02 2024	SELL Open market or private sale	$242,340 $121.17 p/Share	2,000 Reduced 0.47%	427,025 Ordinary Shares
Nov 01 2024	SELL Open market or private sale	$110,840 $110.84 p/Share	1,000 Reduced 0.23%	428,976 Ordinary Shares
Mar 05 2024	SELL Payment of exercise price or tax liability	$2,636,903 $117.53 p/Share	22,436 Reduced 4.96%	429,809 Ordinary Shares
Mar 01 2024	BUY Grant, award, or other acquisition	-	50,187 Added 9.99%	452,245 Ordinary Shares
Jan 17 2024	SELL Payment of exercise price or tax liability	$1,458,746 $119.13 p/Share	12,245 Reduced 2.96%	402,058 Ordinary Shares
Jan 17 2024	BUY Grant, award, or other acquisition	-	26,545 Added 6.02%	414,303 Ordinary Shares
Mar 05 2023	SELL Payment of exercise price or tax liability	$3,124,311 $142.78 p/Share	21,882 Reduced 5.34%	387,584 Ordinary Shares
Mar 03 2023	BUY Grant, award, or other acquisition	-	42,388 Added 9.38%	409,466 Ordinary Shares
Feb 01 2023	SELL Open market or private sale	$155,790 $155.79 p/Share	1,000 Reduced 0.27%	367,078 Ordinary Shares
Jan 03 2023	SELL Open market or private sale	$479,370 $159.79 p/Share	3,000 Reduced 0.81%	368,078 Ordinary Shares
Dec 01 2022	SELL Open market or private sale	$157,000 $157.0 p/Share	1,000 Reduced 0.27%	371,078 Ordinary Shares
Nov 10 2022	SELL Open market or private sale	$300,000 $150.0 p/Share	2,000 Reduced 0.53%	372,028 Ordinary Shares
Oct 03 2022	SELL Open market or private sale	$6,099,975 $135.0 p/Share	45,185 Reduced 10.78%	374,028 Ordinary Shares

Also insider at

SLRN

ACELYRIN, Inc.

Director

BCC

Bruce C Cozadd

Chairman & CEO

Dublin 4, L2

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Value

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

Operation

Value

Type

News

Receive news related to Jazz Pharmaceuticals plc

Track Activities on JAZZ

Account